Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Charmacy Pharmaceutical CoHKSE:02289 76 Pretax Margin % is 1.42% as of Dec. 2025, which is 9% below its 10-year median of 1.56. GuruFocus rates HKSE:02289 with a GF Score™ of 76/100 and a GF Value™ of HK$8.38 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 119 Medical Distribution companies, Charmacy Pharmaceutical Co ranks worse than 63.87% on this metric.
The historical rank and industry rank for Charmacy Pharmaceutical Co's Pretax Margin % or its related term are showing as below:
HKSE:02289'
s Pretax Margin % Range Over the Past 10 Years
Min: 0.87 Med: 1.56 Max: 2.92
Current: 1.47
HKSE:02289's Pretax Margin % is ranked worse than 63.87% of 119
companies
in the Medical Distribution industry
Industry Median: 2.31
vs HKSE:02289: 1.47
Charmacy Pharmaceutical Co (HKSE:02289) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Charmacy Pharmaceutical Co Pretax Margin % Related Terms
Charmacy Pharmaceutical Co Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02289 vs MCK, COR, CAH: Pretax Margin % Comparison
For the Medical Distribution subindustry, Charmacy Pharmaceutical Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Charmacy Pharmaceutical Co Pretax Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Charmacy Pharmaceutical Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Charmacy Pharmaceutical Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Charmacy Pharmaceutical Co (HKSE:02289) has a Pretax Margin % of 1.42% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Charmacy Pharmaceutical Co and its competitors. This is near median its historical median of 1.56. Over the past decade, Charmacy Pharmaceutical Co's Pretax Margin % has ranged from 0.87 to 2.92. According to the industry distribution chart, Charmacy Pharmaceutical Co ranks #76 out of 119 companies in the Medical Distribution industry, placing it in the top 63.9%.
Is Charmacy Pharmaceutical Co's Pretax Margin % too high?
Charmacy Pharmaceutical Co's current Pretax Margin % of 1.42% is near median its 10-year median of 1.56. Over the past 10 years, this metric has ranged from a low of 0.87 to a high of 2.92. The Medical Distribution industry median Pretax Margin % is 2.31. Charmacy Pharmaceutical Co's value of 1.42% is 38.5% below this industry median. Based on the distribution chart, Charmacy Pharmaceutical Co ranks #76 out of 119 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Charmacy Pharmaceutical Co has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Charmacy Pharmaceutical Co's Pretax Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Charmacy Pharmaceutical Co ranks #76 out of 119 companies for Pretax Margin %. This places Charmacy Pharmaceutical Co in the lower half of its industry. The industry median Pretax Margin % is 2.31. Charmacy Pharmaceutical Co's value of 1.42% is 38.5% below this benchmark. Historically, Charmacy Pharmaceutical Co's own Pretax Margin % has ranged from 0.87 to 2.92 over the past decade. While the company's 10-year median is 1.56 vs. the industry median of 2.31, Charmacy Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Distribution company?
The median Pretax Margin % among Medical Distribution companies is 2.31, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Charmacy Pharmaceutical Co's current Pretax Margin % of 1.42% is 38.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Charmacy Pharmaceutical Co and its competitors. For the Medical Distribution industry, the median Pretax Margin % is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Charmacy Pharmaceutical Co's current Pretax Margin % is 1.42%, which is near median its own 10-year median of 1.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charmacy Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Charmacy Pharmaceutical Co (HKSE:02289) is currently considered Possible Value Trap. The stock's GF Value™ is HK$8.38, compared to a current price of HK$5.50 — trading 34.4% below its estimated fair value. The current Pretax Margin % is 1.42%, which is near median its 10-year median of 1.56 and 38.5% below the Medical Distribution industry median of 2.31. Charmacy Pharmaceutical Co's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Charmacy Pharmaceutical Co (HKSE:02289), the current Pretax Margin % is 1.42% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Charmacy Pharmaceutical Co (HKSE:02289) Overvalued in 2026?
Based on GuruFocus' analysis, Charmacy Pharmaceutical Co stock appears to be undervalued.
The current stock price of HK$5.50 is trading 34.4% below its estimated GF Value™ of HK$8.38.
GuruFocus considers Charmacy Pharmaceutical Co to be Possible Value Trap.
Key valuation signals for HKSE:02289:
Pretax Margin %: 1.42% (near median its 10-year median of 1.56)
GF Value™: HK$8.38 vs. price of HK$5.50 (34.4% below fair value)
Industry Position: 38.5% below the Medical Distribution median (#76 of 119)
No single metric tells the full story. See the HKSE:02289 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Charmacy Pharmaceutical Co Ltd operates within the pharmaceutical distribution industry, with a primary focus on the distribution of pharmaceutical products. The principal business activities encompass the wholesale of pharmaceuticals and related services, along with road transportation and cargo warehousing. The company's distribution network covers Southern China and surrounding areas including Fujian province. All the group's operations are located in China.
76GF Score
Get the complete analysis for HKSE:02289
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02289 has been successfully added to your 
